Specialized Diets for Asthma
(INHALE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine how different diets can help manage asthma and improve lung function. Participants will follow one of three diets: a standard healthy diet (DGA Diet), a healthy diet with added medium chain triglycerides (MCT Diet), or a ketogenic diet (KETO Diet, low-carb, high-fat). Adults diagnosed with partly controlled or uncontrolled asthma and who have stable medication use might be suitable candidates. This trial could be appropriate for those whose asthma affects daily life and who are open to trying a new diet for a week. As an unphased trial, it offers a unique opportunity to explore innovative dietary approaches to asthma management.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it requires that your asthma medication has been stable for at least 2 months before joining. This suggests you should continue your current asthma treatment without changes.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
A previous study demonstrated potential benefits of the Dietary Guidelines for Americans (DGA) diet for people with asthma. The DASH diet, similar to the DGA diet, improved asthma symptoms in children and teens, suggesting the DGA diet might also be safe and beneficial for asthma.
Research has shown that adding medium-chain triglycerides (MCTs) to a diet is generally safe. MCTs provide quick energy and are recommended as a safe dietary treatment for epilepsy, indicating their safety for other uses as well.
Studies have shown that the ketogenic (KETO) diet can reduce asthma symptoms by lowering airway inflammation. It is considered safe for long-term use, particularly for weight loss.
Overall, these diets have been studied and found safe for various health conditions. However, individual experiences may vary, and discussing dietary changes with a healthcare provider is always best.12345Why are researchers excited about this trial's treatments?
Researchers are excited about these treatments for asthma because they explore how specific diets might impact asthma management. Unlike traditional treatments like inhalers and medications that target symptoms, these diets, including the Dietary Guidelines for Americans (DGA) Diet, the Ketogenic (KETO) Diet, and a Medium Chain Triglyceride (MCT) supplemented diet, aim to modify inflammation and metabolic pathways that could influence asthma. The KETO Diet, known for its high-fat, low-carb approach, may alter energy metabolism in a way that affects airway inflammation. Meanwhile, the MCT supplemented DGA Diet introduces medium chain triglycerides, which could have unique anti-inflammatory effects. This dietary approach is unique because it could potentially offer a non-pharmacological way to manage asthma, which is an exciting prospect for both patients and researchers.
What evidence suggests that this trial's dietary treatments could be effective for asthma?
Research has shown that changing diet can help control asthma. In this trial, participants will follow different dietary approaches to evaluate their effects on asthma management. One group will adhere to the Dietary Guidelines for Americans, which recommend balanced eating and support evidence that diet affects health. Another group will follow a diet consistent with these guidelines but supplemented with medium-chain triglycerides (MCTs), which can lead to ketosis, a state that might help manage asthma by reducing inflammation. Additionally, a separate group will follow the ketogenic diet, high in fats and low in carbs, which studies suggest could decrease airway inflammation and lessen asthma symptoms. Each dietary approach offers a possible way to improve asthma control.15678
Who Is on the Research Team?
Jacob T Mey, PhD, RD
Principal Investigator
Pennington Biomedical Research Center
Are You a Good Fit for This Trial?
This trial is for adults aged 18-65 with a BMI of 18.5-29.99 who have asthma diagnosed by a specialist and partly controlled or uncontrolled symptoms, as shown by an Asthma Control Test score ≤22. Participants must have stable asthma medication use and own a device compatible with the ZEPHYRx platform.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Lead-in
Participants undergo a lead-in period before starting the dietary interventions
Dietary Intervention
Participants follow three distinct 7-day dietary approaches with a washout period between each
Follow-up
Participants are monitored for safety and effectiveness after the dietary interventions
What Are the Treatments Tested in This Trial?
Interventions
- DGA Diet
- KETO Diet
- MCT Diet
DGA Diet is already approved in United States for the following indications:
- General health and wellness
- Chronic disease prevention
- Weight management
Find a Clinic Near You
Who Is Running the Clinical Trial?
Pennington Biomedical Research Center
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator